Press release

Business Wire1 March 2026

TVCMALL at MWC 2026: Leading Mobile Accessories Wholesale and Smarter Sourcing
Read More »
Business Wire1 March 2026

VZLA Investors Have Opportunity to Join Vizsla Silver Corp. Fraud Investigation with the Schall Law Firm
Read More »
Business Wire1 March 2026

SEVN Investors Have the Opportunity to Join Investigation of Seven Hills Realty Trust with the Schall Law Firm
Read More »
Business Wire1 March 2026

KORE Investors Have the Opportunity to Join Investigation of KORE Group Holdings, Inc. with the Schall Law Firm
Read More »
Press Release

Cision PR Newswire1 March 2026

MWC 2026 Preview | DOOGEE AI Redefines Exploration: A Full-Scenario Ecosystem
Read More »
Business Wire28 February 2026

AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation With the Schall Law Firm
Read More »
Business Wire28 February 2026

KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC)
Read More »
Business Wire28 February 2026

WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
Read More »
Cision PR Newswire28 February 2026

Well-grounded Confidence! How China’s domestic growth drivers propel a strong start to its 15th Five-Year Plan
Read More »
Press Release

Cision PR Newswire28 February 2026

PL-Universe with Stanford: Groundbreaking Physical AI & Robot Event Successfully Concluded
Read More »

Previous page Next page